Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics 2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–596.

PubMed  Google Scholar 

World Health Organization. Global action plan for the prevention and control of NCDs 2013-2020. WHO press. Geneva: World Health Organization. Available at: https://wwwwhoint/nmh/publications/ncd-action-plan/en/ Last access on 29 Jul 2020

Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation web addenda. Eur Heart J. 2018;39:119–77.

Article  Google Scholar 

Bahit MC, Kochar A, Granger CB. Post-myocardial infarction heart failure. JACC Heart Fail. 2018;6:179–86.

Article  Google Scholar 

Hellermann JP, Jacobsen SJ, Gersh BJ, et al. Heart failure after myocardial infarction: a review. Am J Med. 2002;113:324–30.

Article  Google Scholar 

Dagres N, Hindricks G. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? Eur Heart J. 2013;34:1964–71.

Article  Google Scholar 

Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001;3:315–22.

CAS  Article  Google Scholar 

Chew DS, Heikki H, Schmidt G, et al. Change in left ventricular ejection fraction following first myocardial infarction and outcome. JACC Clin Electrophysiol. 2018;4:672–82.

Article  Google Scholar 

Dunlay SM, Roger VL, Weston SA, Jiang R, Redfield MM. Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail. 2012;5:720–6.

Article  Google Scholar 

Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2129–200.

Article  Google Scholar 

Elgendy I, Mahtta D, Pepine CJ. Medical therapy for heart failure caused by ischemic heart disease. Circ Res. 2019;124:1520–35.

CAS  Article  Google Scholar 

Braunwald E. Heart failure. JACC. Heart Fail. 2013;1:1–20.

Google Scholar 

Gjesdal O, Bluemke DA, Lima JA. Cardiac remodeling at the population level-risk factors, screening, and outcomes. Nat Rev Cardiol. 2011;8:673.

Article  Google Scholar 

Abbate A, Biondi-Zoccai GG, Baldi A. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol. 2002;193:145–53.

CAS  Article  Google Scholar 

Chew DS, Wilton SB, Kavanagh K, et al. Left ventricular ejection fraction reassessment post–myocardial infarction: current clinical practice and determinants of adverse remodeling. Am Heart J. 2018;198:91–6.

Article  Google Scholar 

Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017;38:774–84.

CAS  PubMed  Google Scholar 

Gopal DM, Sam F. New and emerging biomarkers in left ventricular systolic dysfunction insight into dilated cardiomyopathy. J Cardiovasc Transl Res. 2013;6:516–27.

Article  Google Scholar 

Liu D, Qi X, Li Q, et al. Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction. Biomed Rep. 2016;5:761–5.

CAS  Article  Google Scholar 

DuBrock HM, AbouEzzeddine OF, Redfield MM. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction. PLoS One. 2018;13:e0201836.

Article  Google Scholar 

Bae KH, Kim SW, Choi YK, et al. Serum levels of PCSK9 are associated with coronary angiographic severity in patients with acute coronary syndrome. Diabetes Metab J. 2018;42:207–14.

Article  Google Scholar 

Almontashiri NAM, Vilmundarson RO, Ghasemzadeh N, et al. Plasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studies. PLoS One. 2014;9:e106294.

Article  Google Scholar 

Bayes-Genis A, Núñez J, Zannad F, et al. The PCSK9-LDL receptor Axis and outcomes in heart failure. J Am Coll Cardiol. 2017;70:2128–36.

CAS  Article  Google Scholar 

Miñana G, Núñez J, Bayés-Genís A, et al. Role of PCSK9 in the course of ejection fraction change after ST-segment elevation myocardial infarction: a pilot study. ESC Heart Failure. 2020;7:117–22.

Article  Google Scholar 

Minucci MF, Azevedo PS, Polegato BF, Paiva SAR, Zornoff LAM. Heart failure after myocardial infarction: clinical implications and treatment. Clin Cardiol. 2011;31:410–4.

Article  Google Scholar 

Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003;20:453–8.

CAS  Article  Google Scholar 

Gerber Y, Weston SA, Enriquez-Sarano M. Mortality associated with heart failure after myocardial infarction a contemporary community perspective. Circ Heart Fail. 2016;9:e002460.

Article  Google Scholar 

Bax JJ, Baumgartner H, Ceconi C, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.

Article  Google Scholar 

Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.

Article  Google Scholar 

Vivo R, Krim SR, Krim NR, et al. Care and outcomes of hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure. Circ Heart Fail. 2012;5:167–75.

Article  Google Scholar 

Choi E, Bahrami H, Colin O, et al. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: multi-ethnic study of atherosclerosis. Circ Heart Fail. 2012;5:727–34.

CAS  Article  Google Scholar 

De Abreu M, Mariani J, Gurudi C, et al. Association between biochemical markers and left ventricular dysfunction in the ST-elevation acute myocardial infarction. Arch Cardiol Mex. 2014;84:243–9.

PubMed  Google Scholar 

Cui CJ, Li S, Zhu CG, et al. Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells. J Cell Mol Med. 2016;20:2374–83.

CAS  Article  Google Scholar 

Laugsand LE, Åsvold BO, Vatten LJ, et al. Circulating PCSK9 and risk of myocardial infarction: the HUNT study in Norway. JACC Basic Transl Sci. 2016;1:568–75.

Article  Google Scholar 

Zhu YM, Anderson TJ, Sikdar K, et al. Association of Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) with cardiovascular risk in primary prevention. Arterioscler Thromb Vasc Biol. 2015;35:2254–9.

CAS  Article  Google Scholar 

Leander K, Mälarstig A, Van't Hooft FM, et al. Circulating Proprotein convertase Subtilisin/Kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors. Circulation. 2016;133:1230–9.

CAS  Article  Google Scholar 

Ridker PM, Rifai N, Bradwin G, Rose L. Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events. Eur Heart J. 2016;37:554–60.

CAS  Article  Google Scholar 

Reinstadler SJ, Feistritzer HJ, Klug G, et al. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction. Int J Cardiol. 2016;202:188–93.

Article  Google Scholar 

Zeljković I, Manola S, Radeljić V, et al. Routinely available biomarkers as long-term predictors of developing systolic dysfunction in completely revascularized patients with acute ST elevation myocardial infarction. Acta Clin Croat. 2019;58:95–102.

PubMed  PubMed Central  Google Scholar 

Abbate A, Van Tassell BW, Biondi-Zoccai G, et al. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra remodeling trial (2) (VCUART2) pilot study]. Am J Cardiol. 2013;111:1394–400.

CAS  Article  Google Scholar 

Lakhani HV, Khanal T, Gabi A, et al. Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in west Virginian population. PLoS One. 2018;13:e0205329.

Article  Google Scholar 

Pérez Fernández R, Kaski JC. Interleukin-10 and coronary disease. Rev Esp Cardiol. 2002;55:738–50.

Article  Google Scholar